Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Jan;65(1):20-5.
doi: 10.1136/ard.2005.038471. Epub 2005 May 18.

Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study

J van Aken  1 , H van Dongen, S le Cessie, C F Allaart, F C Breedveld, T W J Huizinga
Affiliations
Comparative Study

Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study

J van Aken et al. Ann Rheum Dis. 2006 Jan.

Abstract

Background: The outcome of undifferentiated arthritis (UA) ranges from remission to rheumatoid arthritis (RA) fulfilling the American College of Rheumatology (ACR) classification criteria.

Objectives: To report the outcome of UA after 1 year of follow up and compare the disease course of patients who presented with UA, but evolved into RA within 1 year (UA-RA group), with that of patients who presented with RA fulfilling the ACR criteria (RA-RA group).

Methods: The diagnosis of 330 patients who presented with UA was recorded at 1 year. The UA-RA and RA-RA groups were then followed up for 3 more years. Outcome measurements were radiographic progression, disease activity, and functional capacity.

Results: From 330 patients who were diagnosed UA, 91 had evolved into RA at 1 year; 62 patients had presented with RA. No significant differences were detected between the UA-RA and RA-RA groups in median Sharp/van der Heijde score at baseline, radiographic progression rates, disease activity, and functional capacity. However, significantly more disease modifying antirheumatic drugs were prescribed in the RA-RA group.

Conclusion: The disease outcome of patients who present with UA that evolves into RA within 1 year is the same as that of patients who present with RA as measured by radiographic progression, disease activity, and functional capacity.

PubMed Disclaimer

Conflict of interest statement

Competing interest: none declared

References

    1. Verpoort K N, van Dongen H, Allaart C F, Toes R E, Breedveld F C, Huizinga T W. Undifferentiated arthritis—disease course assessed in several inception cohorts. Clin Exp Rheumatol 200422(suppl 35)S7 - PubMed
    1. Schellekens G A, Visser H, de Jong B A, van den Hoogen F H, Hazes J M, Breedveld F C.et al The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 200043155–163. - PubMed
    1. Hannonen P, Mottonen T, Hakola M, Oka M. Sulfasalazine in early rheumatoid arthritis. A 48‐week double‐blind, prospective, placebo‐controlled study. Arthritis Rheum 1993361501–1509. - PubMed
    1. Lard L R, Visser H, Speyer I, vander Horst‐Bruinsma I E, Zwinderman A H, Breedveld F C.et al Early versus delayed treatment in patients with recent‐onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001111446–451. - PubMed
    1. Van der Heide A, Jacobs J W, Bijlsma J W, Heurkens A H, Booma‐Frankfort C, van der Veen M J.et al The effectiveness of early treatment with antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996124699–707. - PubMed

Publication types

MeSH terms

Substances